Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing

MT newswire2026/10/05 21:46

05:46 PM EDT, 10/05/2026 (MT Newswires) -- Christopher M Starr, Director, on October 01, 2026, sold 8,400 shares in Monopar Therapeutics (MNPR) for $659,387. Following the Form 4 filing with the SEC, Starr has control over a total of 15,053 common shares of the company, with 5,173 shares held directly and 9,880 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1645469/000143774926032048/xslF345X05/rdgdoc.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35

Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift

CoinEdition•2026/10/10 17:39